Journal
STRUCTURAL CHEMISTRY
Volume 31, Issue 6, Pages 2487-2499Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11224-020-01605-w
Keywords
Drug repurposing; Drug repositioning; SARS-CoV-2; COVID-19; Corona; Antiviral
Ask authors/readers for more resources
The outbreak of severe acute respiratory syndrome coronavirus-2 is causing a serious disaster through coronavirus disease-19 (COVID-19) around the globe. A large segment of the population from every corner of the world is already infected with this dreadful pathogen with a high mortality rate. These numbers are increasing drastically causing a situation of a global pandemic. Although after the continuous scientific efforts, we are still not having any specific drug or vaccine for the SARS-CoV-2 pathogen to date and there is an urgent need to develop a newer therapy to counter the COVID-19 global pandemic. Thus, in the current study, a framework for computational drug repurposing is established, and based on their safety profile, metocurine was chosen as a safe and effective drug candidate for developing therapy against the viral Mpro enzyme of SARS-CoV-2 for the treatment of COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available